™Your Policy Risk Impact Agent
32 chapters · 914 sections in this title.
D.C. Code § 28-4551 Findings
1.0K chars
The Council of the District of Columbia finds that: (1) The excessive prices of prescription drugs in the District of Columbia is threatening the health and welfare of the residents of the District as well as the District government’s ability to ensure that all residents receive …
D.C. Code § 28-4552 Definitions
0.4K chars
For the purposes of this chapter, the term: (1) “Affected party” means any person directly or indirectly affected by excessive prices of patented prescription drugs, including any organization representing such persons or any person or organization representing the public interes…
D.C. Code § 28-4553 Excessive pricing in sales of prescription drugs, a violation of law
0.3K chars
It shall be unlawful for any drug manufacturer or licensee thereof, excluding a point of sale retail seller, to sell or supply for sale or impose minimum resale requirements for a patented prescription drug that results in the prescription drug being sold in the District for an e…
D.C. Code § 28-4554 Burden of proof; determination of excessive pricing
0.9K chars
(a) A prima facie case of excessive pricing shall be established where the wholesale price of a patented prescription drug in the District is over 30% higher than the comparable price in any high income country in which the product is protected by patents or other exclusive marke…
